Diabetes and the treatment of ischemic stroke

被引:7
作者
Su, Enming J. [1 ]
Lawrence, Daniel A. [1 ,2 ]
机构
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Stroke; Tissue plasminogen activator; Thrombolysis; Diabetes; TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; GROWTH-FACTOR-CC; PDGF-CC; INTRAVENOUS THROMBOLYSIS; STANDARD TREATMENT; SIGNALING PATHWAY; INFARCT VOLUME; HYPERGLYCEMIA;
D O I
10.1016/j.jdiacomp.2022.108318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This white paper examines the current challenges for treating ischemic stroke in diabetic patients. The need for a greater understanding of the mechanisms that underlie the relationship between diabetes and the cerebral vascular responses to ischemia is discussed. The critical need to improve the efficacy and safety of thrombolysis is addressed, as is the need for a better characterization the off-target actions of tPA, the only currently approved thrombolytic for the treatment of ischemic stroke.
引用
收藏
页数:4
相关论文
共 83 条
  • [61] Siao CJ, 2002, J NEUROSCI, V22, P3352
  • [62] Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
    Su, Enming J.
    Fredriksson, Linda
    Geyer, Melissa
    Folestad, Erika
    Cale, Jacqueline
    Andrae, Johanna
    Gao, Yamei
    Pietras, Kristian
    Mann, Kris
    Yepes, Manuel
    Strickland, Dudley K.
    Betsholtz, Christer
    Eriksson, Ulf
    Lawrence, Daniel A.
    [J]. NATURE MEDICINE, 2008, 14 (07) : 731 - 737
  • [63] Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
    Su, Enming J.
    Fredriksson, Linda
    Kanzawa, Mia
    Moore, Shannon
    Folestad, Erika
    Stevenson, Tamara K.
    Nilsson, Ingrid
    Sashindranath, Maithili
    Schielke, Gerald P.
    Warnock, Mark
    Ragsdale, Margaret
    Mann, Kris
    Lawrence, Anna-Lisa E.
    Medcalf, Robert L.
    Eriksson, Ulf
    Murphy, Geoffrey G.
    Lawrence, Daniel A.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [64] Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
    Su, Enming Joseph
    Cao, Chunzhang
    Fredriksson, Linda
    Nilsson, Ingrid
    Stefanitsch, Christina
    Stevenson, Tamara K.
    Zhao, Juanjuan
    Ragsdale, Margret
    Sun, Yu-Yo
    Yepes, Manuel
    Kuan, Chia-Yi
    Eriksson, Ulf
    Strickland, Dudley K.
    Lawrence, Daniel A.
    Zhang, Li
    [J]. ACTA NEUROPATHOLOGICA, 2017, 134 (04) : 585 - 604
  • [65] Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice The multicenter rt-PA acute stroke survey
    Tanne, D
    Kasner, SE
    Demchuk, AM
    Koren-Morag, N
    Hanson, S
    Grond, M
    Levine, SR
    [J]. CIRCULATION, 2002, 105 (14) : 1679 - 1685
  • [66] Intensive Versus Standard Treatment of Hyperglycemia in Acute Ischemic Stroke Patient: A Randomized Clinical Trial Subgroups Analysis
    Torbey, Michel T.
    Pauls, Qi
    Gentile, Nina
    Falciglia, Mercedes
    Meurer, William
    Pettigrew, Creed L.
    Durkalski, Valerie L.
    Bleck, Thomas
    Bruno, Askiel
    [J]. STROKE, 2022, 53 (05) : 1510 - 1515
  • [67] Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association
    Tsao, Connie W.
    Aday, Aaron W.
    Almarzooq, Zaid I.
    Alonso, Alvaro
    Beaton, Andrea Z.
    Bittencourt, Marcio S.
    Boehme, Amelia K.
    Buxton, Alfred E.
    Carson, April P.
    Commodore-Mensah, Yvonne
    Elkind, Mitchell S. V.
    Evenson, Kelly R.
    Eze-Nliam, Chete
    Ferguson, Jane F.
    Generoso, Giuliano
    Ho, Jennifer E.
    Kalani, Rizwan
    Khan, Sadiya S.
    Kissela, Brett M.
    Knutson, Kristen L.
    Levine, Deborah A.
    Lewis, Tene T.
    Liu, Junxiu
    Loop, Matthew Shane
    Ma, Jun
    Mussolino, Michael E.
    Navaneethan, Sankar D.
    Perak, Amanda Marma
    Poudel, Remy
    Rezk-Hanna, Mary
    Roth, Gregory A.
    Schroeder, Emily B.
    Shah, Svati H.
    Thacker, Evan L.
    VanWagner, Lisa B.
    Virani, Salim S.
    Voecks, Jenifer H.
    Wang, Nae-Yuh
    Yaffe, Kristine
    Martin, Seth S.
    [J]. CIRCULATION, 2022, 145 (08) : E153 - E639
  • [68] EXCITOTOXIN-INDUCED NEURONAL DEGENERATION AND SEIZURE ARE MEDIATED BY TISSUE-PLASMINOGEN ACTIVATOR
    TSIRKA, SE
    GUALANDRIS, A
    AMARAL, DG
    STRICKLAND, S
    [J]. NATURE, 1995, 377 (6547) : 340 - 344
  • [69] Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden A Meta-analysis
    Tsivgoulis, Georgios
    Zand, Ramin
    Katsanos, Aristeidis H.
    Turc, Guillaume
    Nolte, Christian H.
    Jung, Simon
    Cordonnier, Charlotte
    Fiebach, Jochen B.
    Scheitz, Jan F.
    Klinger-Gratz, Pascal P.
    Oppenheim, Catherine
    Goyal, Nitin
    Safouris, Apostolos
    Mattle, Heinrich P.
    Alexandrov, Anne W.
    Schellinger, Peter D.
    Alexandrov, Andrei V.
    [J]. JAMA NEUROLOGY, 2016, 73 (06) : 675 - 683
  • [70] Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)
    von Kummer, Ruediger
    Mori, Etsuro
    Truelsen, Thomas
    Jensen, Jens-Kristian S.
    Gronning, Bjorn A.
    Fiebach, Jochen B.
    Lovblad, Karl-Olof
    Pedraza, Salvador
    Romero, Javier M.
    Chabriat, Hugues
    Chang, Ku-Chou
    Davalos, Antoni
    Ford, Gary A.
    Grotta, James
    Kaste, Markku
    Schwamm, Lee H.
    Shuaib, Ashfaq
    Albers, Gregory W.
    [J]. STROKE, 2016, 47 (12) : 2880 - 2887